Xadago is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Us Worldmeds, Llc. The primary component is Safinamide Mesylate.
| Product ID | 27505-110_0e434cb6-5220-44c2-a9cc-0b085946a007 | 
| NDC | 27505-110 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Xadago | 
| Generic Name | Safinamide Mesylate | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2017-05-08 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA207145 | 
| Labeler Name | US WorldMeds, LLC | 
| Substance Name | SAFINAMIDE MESYLATE | 
| Active Ingredient Strength | 50 mg/1 | 
| Pharm Classes | Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2017-05-08 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA207145 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-05-08 | 
| Marketing Category | NDA | 
| Application Number | NDA207145 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-05-08 | 
| Marketing Category | NDA | 
| Application Number | NDA207145 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-05-08 | 
| Ingredient | Strength | 
|---|---|
| SAFINAMIDE MESYLATE | 50 mg/1 | 
| SPL SET ID: | c4d65f28-983f-42b4-bb23-023ae0fe81b2 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 27505-110 | Xadago | safinamide mesylate | 
| 27505-111 | Xadago | safinamide mesylate | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() XADAGO  85842346  4630663 Live/Registered  | 
        ZAMBON S.P.A.  2013-02-06  |